Logo image of PAH3.DE

PORSCHE AUTOMOBIL HLDG-PRF (PAH3.DE) Stock Fundamental Analysis

FRA:PAH3 - Deutsche Boerse Ag - DE000PAH0038 - Currency: EUR

36.76  +0.59 (+1.63%)

Fundamental Rating

4

Taking everything into account, PAH3 scores 4 out of 10 in our fundamental rating. PAH3 was compared to 29 industry peers in the Automobiles industry. While PAH3 has a great health rating, there are worries on its profitability. PAH3 has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year PAH3 has reported negative net income.
PAH3 had a positive operating cash flow in the past year.
Of the past 5 years PAH3 4 years were profitable.
Each year in the past 5 years PAH3 had a positive operating cash flow.
PAH3.DE Yearly Net Income VS EBIT VS OCF VS FCFPAH3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B -15B -20B

1.2 Ratios

PAH3 has a worse Return On Assets (-46.72%) than 93.10% of its industry peers.
The Return On Equity of PAH3 (-57.02%) is worse than 89.66% of its industry peers.
PAH3's Return On Invested Capital of 5.62% is fine compared to the rest of the industry. PAH3 outperforms 65.52% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PAH3 is in line with the industry average of 7.57%.
Industry RankSector Rank
ROA -46.72%
ROE -57.02%
ROIC 5.62%
ROA(3y)-9.78%
ROA(5y)-2.27%
ROE(3y)-12.42%
ROE(5y)-3.83%
ROIC(3y)6.04%
ROIC(5y)6.18%
PAH3.DE Yearly ROA, ROE, ROICPAH3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

PAH3 has a Operating Margin of 99.24%. This is amongst the best in the industry. PAH3 outperforms 100.00% of its industry peers.
PAH3's Operating Margin has been stable in the last couple of years.
The Profit Margin and Gross Margin are not available for PAH3 so they could not be analyzed.
Industry RankSector Rank
OM 99.24%
PM (TTM) N/A
GM N/A
OM growth 3Y-0.12%
OM growth 5Y0.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PAH3.DE Yearly Profit, Operating, Gross MarginsPAH3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PAH3 is destroying value.
The number of shares outstanding for PAH3 remains at a similar level compared to 1 year ago.
PAH3 has about the same amout of shares outstanding than it did 5 years ago.
PAH3 has a worse debt/assets ratio than last year.
PAH3.DE Yearly Shares OutstandingPAH3.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
PAH3.DE Yearly Total Debt VS Total AssetsPAH3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

PAH3 has an Altman-Z score of 1.82. This is not the best score and indicates that PAH3 is in the grey zone with still only limited risk for bankruptcy at the moment.
PAH3 has a Altman-Z score of 1.82. This is in the better half of the industry: PAH3 outperforms 75.86% of its industry peers.
The Debt to FCF ratio of PAH3 is 5.28, which is a neutral value as it means it would take PAH3, 5.28 years of fcf income to pay off all of its debts.
PAH3 has a Debt to FCF ratio of 5.28. This is amongst the best in the industry. PAH3 outperforms 82.76% of its industry peers.
PAH3 has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
PAH3's Debt to Equity ratio of 0.21 is amongst the best of the industry. PAH3 outperforms 89.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 5.28
Altman-Z 1.82
ROIC/WACC0.89
WACC6.3%
PAH3.DE Yearly LT Debt VS Equity VS FCFPAH3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B 40B 50B

2.3 Liquidity

PAH3 has a Current Ratio of 16.13. This indicates that PAH3 is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 16.13, PAH3 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 16.13 indicates that PAH3 has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 16.13, PAH3 belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 16.13
Quick Ratio 16.13
PAH3.DE Yearly Current Assets VS Current LiabilitesPAH3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1

3. Growth

3.1 Past

PAH3 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -494.45%.
The Revenue for PAH3 has decreased by -34.13% in the past year. This is quite bad
The Revenue has been decreasing by -5.37% on average over the past years.
EPS 1Y (TTM)-494.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-900.89%
Revenue 1Y (TTM)-34.13%
Revenue growth 3Y-9.48%
Revenue growth 5Y-5.37%
Sales Q2Q%-57.91%

3.2 Future

Based on estimates for the next years, PAH3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.56% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2.87%
EPS Next 2Y7.91%
EPS Next 3Y5.39%
EPS Next 5Y9.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PAH3.DE Yearly Revenue VS EstimatesPAH3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B
PAH3.DE Yearly EPS VS EstimatesPAH3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PAH3. In the last year negative earnings were reported.
PAH3 is valuated cheaply with a Price/Forward Earnings ratio of 3.04.
Based on the Price/Forward Earnings ratio, PAH3 is valued cheaply inside the industry as 89.66% of the companies are valued more expensively.
PAH3's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.81.
Industry RankSector Rank
PE N/A
Fwd PE 3.04
PAH3.DE Price Earnings VS Forward Price EarningsPAH3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

PAH3's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PAH3 is cheaper than 72.41% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PAH3 is valued cheaper than 89.66% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.93
EV/EBITDA 2.95
PAH3.DE Per share dataPAH3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.91%
EPS Next 3Y5.39%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.28%, PAH3 is a good candidate for dividend investing.
PAH3's Dividend Yield is comparable with the industry average which is at 6.37.
PAH3's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 5.28%

5.2 History

The dividend of PAH3 has a limited annual growth rate of 2.98%.
Dividend Growth(5Y)2.98%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

PAH3 has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of PAH3 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-3.91%
EPS Next 2Y7.91%
EPS Next 3Y5.39%
PAH3.DE Yearly Income VS Free CF VS DividendPAH3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B -15B -20B

PORSCHE AUTOMOBIL HLDG-PRF

FRA:PAH3 (4/30/2025, 5:02:59 PM)

36.76

+0.59 (+1.63%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)05-14 2025-05-14
Inst Owners15.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.63B
Analysts53.64
Price Target40.02 (8.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.28%
Yearly Dividend2.56
Dividend Growth(5Y)2.98%
DP-3.91%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.04%
PT rev (3m)-0.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.28%
EPS NY rev (3m)-16.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-100%
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.04
P/S 1.64
P/FCF 3.93
P/OCF 3.93
P/B 0.16
P/tB 0.16
EV/EBITDA 2.95
EPS(TTM)-65.36
EYN/A
EPS(NY)12.11
Fwd EY32.93%
FCF(TTM)9.35
FCFY25.42%
OCF(TTM)9.35
OCFY25.42%
SpS22.41
BVpS229.28
TBVpS229.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -46.72%
ROE -57.02%
ROCE 7.98%
ROIC 5.62%
ROICexc 5.95%
ROICexgc 5.95%
OM 99.24%
PM (TTM) N/A
GM N/A
FCFM 41.71%
ROA(3y)-9.78%
ROA(5y)-2.27%
ROE(3y)-12.42%
ROE(5y)-3.83%
ROIC(3y)6.04%
ROIC(5y)6.18%
ROICexc(3y)6.21%
ROICexc(5y)6.32%
ROICexgc(3y)6.21%
ROICexgc(5y)6.33%
ROCE(3y)8.58%
ROCE(5y)8.78%
ROICexcg growth 3Y-8.5%
ROICexcg growth 5Y-7.91%
ROICexc growth 3Y-8.5%
ROICexc growth 5Y-7.78%
OM growth 3Y-0.12%
OM growth 5Y0.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 5.28
Debt/EBITDA 2.19
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 10.74
Cash Conversion 42.01%
Profit Quality N/A
Current Ratio 16.13
Quick Ratio 16.13
Altman-Z 1.82
F-Score3
WACC6.3%
ROIC/WACC0.89
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-494.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-900.89%
EPS Next Y-2.87%
EPS Next 2Y7.91%
EPS Next 3Y5.39%
EPS Next 5Y9.56%
Revenue 1Y (TTM)-34.13%
Revenue growth 3Y-9.48%
Revenue growth 5Y-5.37%
Sales Q2Q%-57.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.28%
EBIT growth 3Y-9.59%
EBIT growth 5Y-5.09%
EBIT Next Year290.37%
EBIT Next 3Y25.58%
EBIT Next 5YN/A
FCF growth 1Y-23.64%
FCF growth 3Y25.04%
FCF growth 5Y14.85%
OCF growth 1Y-23.64%
OCF growth 3Y25.04%
OCF growth 5Y14.66%